RMDN3 and coronary artery disorder: Similarly, cardiac PTPIP51-specific knockdown significantly reduces nodule size and cardiac injury after myocardial infiltration of I/R, suggesting that PTPIP51 could be a therapeutic target for ischemic heart disease (Qiao et al., 2017).